WHITTIER TRUST CO - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 151 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
WHITTIER TRUST CO ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$224
-54.4%
3810.0%0.00%
Q2 2023$491
-26.3%
3810.0%0.00%
Q1 2023$666
-44.3%
3810.0%0.00%
Q4 2022$1,196
-40.2%
3810.0%0.00%
Q3 2022$2,000
-50.0%
381
-63.6%
0.00%
Q2 2022$4,000
-33.3%
1,0480.0%0.00%
Q1 2022$6,000
-25.0%
1,0480.0%0.00%
Q4 2021$8,000
+166.7%
1,048
+175.1%
0.00%
Q3 2021$3,000
-40.0%
3810.0%0.00%
Q2 2021$5,0000.0%3810.0%0.00%
Q1 2021$5,000
-16.7%
3810.0%0.00%
Q4 2020$6,000
+50.0%
3810.0%0.00%
Q3 2020$4,000
+33.3%
3810.0%0.00%
Q2 2020$3,0000.0%381
-11.6%
0.00%
Q1 2020$3,000
-25.0%
4310.0%0.00%
Q4 2019$4,000
-63.6%
431
-63.5%
0.00%
Q3 2019$11,000
+175.0%
1,181
+210.0%
0.00%
Q2 2019$4,0000.0%3810.0%0.00%
Q1 2019$4,0000.0%3810.0%0.00%
Q4 2018$4,000
-33.3%
3810.0%0.00%
Q3 2018$6,000
+20.0%
3810.0%0.00%
Q2 2018$5,0003810.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,032,980$12,950,0001.82%
EcoR1 Capital, LLC 2,308,079$14,702,0001.54%
Alexandria Capital, LLC 1,005,119$6,403,0001.05%
Casdin Capital, LLC 1,455,000$9,268,0000.98%
Rhenman & Partners Asset Management AB 700,000$4,459,0000.62%
Bellevue Group AG 3,850,000$24,525,0000.48%
GREAT POINT PARTNERS LLC 633,505$4,035,0000.42%
WASATCH ADVISORS LP 5,938,434$37,828,0000.39%
361 CAPITAL LLC 109,161$695,0000.32%
Ceeto Capital Group, LLC 50,000$319,0000.26%
View complete list of SANGAMO THERAPEUTICS INC shareholders